• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病 APP23 小鼠模型中的转谷氨酰胺酶-2 相互作用组。

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer's Disease.

机构信息

Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.

School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.

出版信息

Cells. 2022 Jan 24;11(3):389. doi: 10.3390/cells11030389.

DOI:10.3390/cells11030389
PMID:35159198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8834516/
Abstract

Amyloid-beta (Aβ) deposition in the brain is closely linked with the development of Alzheimer's disease (AD). Unfortunately, therapies specifically targeting Aβ deposition have failed to reach their primary clinical endpoints, emphasizing the need to broaden the search strategy for alternative targets/mechanisms. Transglutaminase-2 (TG2) catalyzes post-translational modifications, is present in AD lesions and interacts with AD-associated proteins. However, an unbiased overview of TG2 interactors is lacking in both control and AD brain. Here we aimed to identify these interactors using a crossbreed of the AD-mimicking APP23 mouse model with wild type and TG2 knock-out (TG2) mice. We found that absence of TG2 had no (statistically) significant effect on Aβ pathology, soluble brain levels of Aβ and Aβ, and mRNA levels of TG family members compared to APP23 mice at 18 months of age. Quantitative proteomics and network analysis revealed a large cluster of TG2 interactors involved in synaptic transmission/assembly and cell adhesion in the APP23 brain typical of AD. Comparative proteomics of wild type and TG2 brains revealed a TG2-linked pathological proteome consistent with alterations in both pathways. Our data show that TG2 deletion leads to considerable network alterations consistent with a TG2 role in (dys)regulation of synaptic transmission and cell adhesion in APP23 brains.

摘要

脑内淀粉样蛋白-β(Aβ)沉积与阿尔茨海默病(AD)的发展密切相关。不幸的是,专门针对 Aβ 沉积的治疗方法未能达到其主要临床终点,这强调了需要扩大对替代靶标/机制的搜索策略。转谷氨酰胺酶-2(TG2)催化翻译后修饰,存在于 AD 病变中,并与 AD 相关蛋白相互作用。然而,在对照和 AD 脑中,缺乏对 TG2 相互作用物的无偏见概述。在这里,我们使用 AD 模拟 APP23 小鼠模型与野生型和 TG2 敲除(TG2)小鼠的杂交体来确定这些相互作用物。我们发现,与 APP23 小鼠相比,18 个月时,TG2 的缺失对 Aβ 病理学、可溶性脑 Aβ 水平和 TG 家族成员的 mRNA 水平没有(统计学上)显著影响。定量蛋白质组学和网络分析显示,APP23 脑内存在一大簇与突触传递/组装和细胞黏附相关的 TG2 相互作用物,这是 AD 的典型特征。野生型和 TG2 脑的比较蛋白质组学揭示了与两条通路改变一致的 TG2 相关病理蛋白质组。我们的数据表明,TG2 缺失导致相当大的网络改变,这与 TG2 在 APP23 脑中(失调)调节突触传递和细胞黏附的作用一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/311904d42cef/cells-11-00389-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/21b6633b1607/cells-11-00389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/b9b03de4e6fc/cells-11-00389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/16ccfd746bcb/cells-11-00389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/aae397f301cb/cells-11-00389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/20ded82e34ff/cells-11-00389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/311904d42cef/cells-11-00389-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/21b6633b1607/cells-11-00389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/b9b03de4e6fc/cells-11-00389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/16ccfd746bcb/cells-11-00389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/aae397f301cb/cells-11-00389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/20ded82e34ff/cells-11-00389-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d16/8834516/311904d42cef/cells-11-00389-g006.jpg

相似文献

1
The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer's Disease.阿尔茨海默病 APP23 小鼠模型中的转谷氨酰胺酶-2 相互作用组。
Cells. 2022 Jan 24;11(3):389. doi: 10.3390/cells11030389.
2
Absence of tissue transglutaminase reduces amyloid-beta pathology in APP23 mice.缺乏组织转谷氨酰胺酶可减少 APP23 小鼠的淀粉样β病理。
Neuropathol Appl Neurobiol. 2022 Jun;48(4):e12796. doi: 10.1111/nan.12796. Epub 2022 Feb 23.
3
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.用 11C-PIB 进行小鼠脑内淀粉样蛋白的纵向成像:阿尔茨海默病 APP23、Tg2576 和 APPswe-PS1dE9 小鼠模型的比较。
J Nucl Med. 2013 Aug;54(8):1434-41. doi: 10.2967/jnumed.112.110163. Epub 2013 Jul 5.
4
The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice.淀粉样前体蛋白(APP23)和β-淀粉样肽(APP48)转基因小鼠的 Aβ 相关神经元变性类型不同。
Acta Neuropathol Commun. 2013 Nov 18;1(1):77. doi: 10.1186/2051-5960-1-77.
5
The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.APP23转基因小鼠中β淀粉样肽负荷的演变:对阿尔茨海默病中β淀粉样蛋白沉积的影响。
Mol Med. 2001 Sep;7(9):609-18.
6
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.纤维状 Aβ 在阿尔茨海默病小鼠模型中引发小胶质细胞蛋白质组改变和功能障碍。
Elife. 2020 Jun 8;9:e54083. doi: 10.7554/eLife.54083.
7
Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?人类和鼠类阿尔茨海默病中转甲状腺素蛋白的神经元产生:是否具有保护作用?
J Neurosci. 2011 Aug 31;31(35):12483-90. doi: 10.1523/JNEUROSCI.2417-11.2011.
8
TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease.转谷氨酰胺酶2促进β淀粉样蛋白聚集:对阿尔茨海默病内质网-线粒体相互作用、钙稳态及突触功能的影响
Biomed Pharmacother. 2023 Jun;162:114596. doi: 10.1016/j.biopha.2023.114596. Epub 2023 Mar 28.
9
Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains.转基因小鼠和阿尔茨海默病大脑中β-淀粉样蛋白化学结构与淀粉样斑块形态的比较分析。
J Biol Chem. 2001 Apr 20;276(16):12991-8. doi: 10.1074/jbc.M007859200. Epub 2001 Jan 10.
10
Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.Aβ 诱导的阿尔茨海默病相关 tau 病理扩散加速及其与朊病毒蛋白的关系。
Acta Neuropathol. 2019 Dec;138(6):913-941. doi: 10.1007/s00401-019-02053-5. Epub 2019 Aug 14.

引用本文的文献

1
The Alkaloid Gelsemine Reduces Aβ Peptide Toxicity by Targeting Transglutaminase Type 2 Enzyme.生物碱钩吻素通过靶向组织转谷氨酰胺酶2减轻β淀粉样肽毒性。
Plants (Basel). 2025 May 21;14(10):1556. doi: 10.3390/plants14101556.
2
In silico studies of the open form of human tissue transglutaminase.人组织转谷氨酰胺酶开放形式的计算机模拟研究。
Sci Rep. 2024 Jul 10;14(1):15981. doi: 10.1038/s41598-024-66348-8.
3
Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases.转谷氨酰胺酶 2 在神经退行性疾病中的发病机制贡献和治疗意义。

本文引用的文献

1
Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.淀粉样斑块的细胞外蛋白成分及其在阿尔茨海默病病理中的作用。
Mol Neurodegener. 2021 Aug 28;16(1):59. doi: 10.1186/s13024-021-00465-0.
2
Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis.转谷氨酰胺酶 2 在细胞死亡、存活和纤维化中的作用。
Cells. 2021 Jul 20;10(7):1842. doi: 10.3390/cells10071842.
3
Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials.从第二代抗淀粉样蛋白单克隆抗体临床试验中吸取的经验教训。
Int J Mol Sci. 2024 Feb 17;25(4):2364. doi: 10.3390/ijms25042364.
4
Tissue engineering modalities in skeletal muscles: focus on angiogenesis and immunomodulation properties.组织工程学在骨骼肌中的应用模式:关注血管生成和免疫调节特性。
Stem Cell Res Ther. 2023 Apr 15;14(1):90. doi: 10.1186/s13287-023-03310-x.
5
Emerging Roles of Extracellular Vesicles in Alzheimer's Disease: Focus on Synaptic Dysfunction and Vesicle-Neuron Interaction.细胞外囊泡在阿尔茨海默病中的新兴作用:聚焦于突触功能障碍和囊泡-神经元相互作用。
Cells. 2022 Dec 23;12(1):63. doi: 10.3390/cells12010063.
Dement Geriatr Cogn Disord. 2020;49(4):334-348. doi: 10.1159/000511506. Epub 2020 Dec 15.
4
αB-crystallin as a promising target in pathological conditions - A review.αB晶状体蛋白作为病理状态下一个有前景的靶点——综述
Ann Agric Environ Med. 2020 Sep 11;27(3):326-334. doi: 10.26444/aaem/111759. Epub 2019 Sep 6.
5
Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in Mice.转谷氨酰胺酶 2 耗竭可减轻小鼠 α-突触核蛋白介导的毒性。
Neuroscience. 2020 Aug 10;441:58-64. doi: 10.1016/j.neuroscience.2020.05.047. Epub 2020 Jun 2.
6
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.线粒体功能障碍在阿尔茨海默病发病机制中的作用:最新进展
Mol Neurodegener. 2020 May 29;15(1):30. doi: 10.1186/s13024-020-00376-6.
7
Interaction between tissue transglutaminase and amyloid-beta: Protein-protein binding versus enzymatic crosslinking.组织转谷氨酰胺酶与淀粉样β肽的相互作用:蛋白-蛋白结合与酶交联。
Anal Biochem. 2020 Mar 1;592:113578. doi: 10.1016/j.ab.2020.113578. Epub 2020 Jan 8.
8
Downregulation of 14-3-3 Proteins in Alzheimer's Disease.阿尔茨海默病中 14-3-3 蛋白的下调。
Mol Neurobiol. 2020 Jan;57(1):32-40. doi: 10.1007/s12035-019-01754-y. Epub 2019 Sep 5.
9
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.载脂蛋白 E 与阿尔茨海默病:发病机制与靶向治疗策略。
Nat Rev Neurol. 2019 Sep;15(9):501-518. doi: 10.1038/s41582-019-0228-7. Epub 2019 Jul 31.
10
Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction.聚焦转谷氨酰胺酶2与硫酸乙酰肝素的相互作用。
Med Sci (Basel). 2019 Jan 4;7(1):5. doi: 10.3390/medsci7010005.